Bacuyong, Romeo .

HRN: 21-95-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2022
CEFTRIAXONE 1G (VIAL)
10/14/2022
10/21/2022
IV
2g
Od
Appendicitis
Waiting Final Action 
10/27/2022
MUPIROCIN 2%, 15G (TUBE)
10/27/2022
11/03/2022
TOPICAL
Apply Thinly
BID
Sacral Ulcers
Waiting Final Action 
10/28/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/28/2022
11/04/2022
IV
4.5g
Q6hours
Sepsis
Waiting Final Action 
10/28/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/28/2022
11/04/2022
IV
600mg
Q8hours
Sepsis
Waiting Final Action 
10/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/29/2022
11/04/2022
IV
600mg
Q6
Aspiration Pneumonia, Septicemia
Waiting Final Action 
11/06/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/06/2022
11/10/2022
IV
600mg
Q6
Aspiration Pneumonia
Waiting Final Action 
11/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2022
11/10/2022
IV
4.5gm
Q6
Aspiration Pneumonia
Waiting Final Action 
11/08/2022
MEBENDAZOLE 500MG (TAB)
11/08/2022
11/08/2022
ORAL
500mg
1 Dose
Hookworm Infection
Waiting Final Action 
11/09/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/09/2022
11/15/2022
IV
4.5g
OD
Intraabdominal Infection
Waiting Final Action 
11/09/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/09/2022
11/15/2022
IV
600 Mg
Q6
Wound Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: